Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
J Virol. 2023 Mar 30;97(3):e0176322. doi: 10.1128/jvi.01763-22. Epub 2023 Mar 6.
Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of Kaposi sarcoma (KS), the plasmablastic form of multicentric Castleman's disease, and primary effusion lymphoma. In sub-Saharan Africa, KS is the most common HIV-related malignancy and one of the most common childhood cancers. Immunosuppressed patients, including HIV-infected patients, are more prone to KSHV-associated disease. KSHV encodes a viral protein kinase (vPK) that is expressed from ORF36. KSHV vPK contributes to the optimal production of infectious viral progeny and upregulation of protein synthesis. To elucidate the interactions of vPK with cellular proteins in KSHV-infected cells, we used a bottom-up proteomics approach and identified host protein ubiquitin-specific peptidase 9X-linked (USP9X) as a potential interactor of vPK. Subsequently, we validated this interaction using a co-immunoprecipitation assay. We report that both the ubiquitin-like and the catalytic domains of USP9X are important for association with vPK. To uncover the biological relevance of the USP9X/vPK interaction, we investigated whether the knockdown of USP9X would modulate viral reactivation. Our data suggest that depletion of USP9X inhibits both viral reactivation and the production of infectious virions. Understanding how USP9X influences the reactivation of KSHV will provide insights into how cellular deubiquitinases regulate viral kinase activity and how viruses co-opt cellular deubiquitinases to propagate infection. Hence, characterizing the roles of USP9X and vPK during KSHV infection constitutes a first step toward identifying a potentially critical interaction that could be targeted by future therapeutics. Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of Kaposi sarcoma (KS), the plasmablastic form of multicentric Castleman's disease, and primary effusion lymphoma. In sub-Saharan Africa, KS is the most common HIV-related malignancy. KSHV encodes a viral protein kinase (vPK) that aids viral replication. To elucidate the interactions of vPK with cellular proteins in KSHV-infected cells, we used an affinity purification approach and identified host protein ubiquitin-specific peptidase 9X-linked (USP9X) as a potential interactor of vPK. Depletion of USP9X inhibits both viral reactivation and the production of infectious virions. Overall, our data suggest a proviral role for USP9X.
卡波氏肉瘤相关疱疹病毒(KSHV)是卡波氏肉瘤(KS)、多中心 Castleman 病的浆细胞样形式和原发性渗出淋巴瘤的病原体。在撒哈拉以南非洲,KS 是最常见的与 HIV 相关的恶性肿瘤之一,也是最常见的儿童癌症之一。包括 HIV 感染者在内的免疫抑制患者更容易发生 KSHV 相关疾病。KSHV 编码一种病毒蛋白激酶(vPK),该蛋白由 ORF36 表达。KSHV vPK 有助于产生感染性病毒后代和上调蛋白质合成。为了阐明 KSHV 感染细胞中 vPK 与细胞蛋白的相互作用,我们使用了一种自下而上的蛋白质组学方法,鉴定了宿主蛋白泛素特异性肽酶 9X 连锁(USP9X)是 vPK 的潜在相互作用蛋白。随后,我们使用共免疫沉淀实验验证了这种相互作用。我们报告说,USP9X 的泛素样和催化结构域对于与 vPK 结合都很重要。为了揭示 USP9X/vPK 相互作用的生物学相关性,我们研究了 USP9X 的敲低是否会调节病毒的重新激活。我们的数据表明,USP9X 的缺失既抑制病毒的重新激活,也抑制感染性病毒粒子的产生。了解 USP9X 如何影响 KSHV 的重新激活将为了解细胞去泛素化酶如何调节病毒激酶活性以及病毒如何利用细胞去泛素化酶来传播感染提供深入的认识。因此,鉴定 USP9X 和 vPK 在 KSHV 感染过程中的作用是识别潜在关键相互作用的第一步,这种相互作用可能成为未来治疗的靶点。卡波氏肉瘤相关疱疹病毒(KSHV)是卡波氏肉瘤(KS)、多中心 Castleman 病的浆细胞样形式和原发性渗出淋巴瘤的病原体。在撒哈拉以南非洲,KS 是最常见的与 HIV 相关的恶性肿瘤。KSHV 编码一种病毒蛋白激酶(vPK),该蛋白促进病毒复制。为了阐明 KSHV 感染细胞中 vPK 与细胞蛋白的相互作用,我们使用亲和纯化方法鉴定了宿主蛋白泛素特异性肽酶 9X 连锁(USP9X)是 vPK 的潜在相互作用蛋白。USP9X 的缺失既抑制病毒的重新激活,也抑制感染性病毒粒子的产生。总的来说,我们的数据表明 USP9X 具有前病毒作用。